National Cancer Institute; Notice of Closed Meetings, 43764 [E8-17245]
Download as PDF
<![CDATA[
43764
Federal Register / Vol. 73, No. 145 / Monday, July 28, 2008 / Notices
Dated: July 21, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–17139 Filed 7–25–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Synthesis
of Stable Isotope-Labeled Steroids as Internal
Standards for the Measurement of
Endogenous Steroid Hormones in Biologic
Samples by Liquid Chromatography.
Date: August 26, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6130
Executive Boulevard, Conference Room 319,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Officer, Special Review
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892–8329, 301–496–7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Altered
Isoflavone Soybeans for Hormone-Responsive
Cancer.
Date: September 8, 2008.
Time: 12:30 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 607, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Marvin L. Salin, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
VerDate Aug<31>2005
18:35 Jul 25, 2008
Jkt 214001
Executive Boulevard, Room 7073, Bethesda,
MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SPORE in
Breast, Brain, GI, HN, Ovarian, and
Pancreatic Cancers.
Date: September 24–25, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Shamala K. Srinivas, PhD,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 8123, Bethesda,
MD 20892, 301–594–1224, ss537t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Discovery
and Development.
Date: October 1–2, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville,
Double Tree Name Changed, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Caron Lyman, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd, Room 8119, Bethesda, MD
20892–8328, 301–451–4761,
lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Clinical
Studies I P01.
Date: October 6–7, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville
Executive Mtg Center, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Majed M. Hamawy, PhD,
MBA, Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8135, Bethesda, MD 20892–8328, 301–594–
5659, mh101v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Clinical
Studies II P01.
Date: October 7, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville,
Double Tree Name Changed, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Peter J. Wirth, PhD,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 8131, Bethesda,
MD 20892–8328, 301–496–7565,
pw2q@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Prevention,
Control and Population Sciences.
Date: October 7–8, 2008.
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville,
Double Tree Name Changed, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Wlodek Lopaczynski, MD,
PhD, Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8131,
Bethesda, MD 20892, 301–594–1402,
lopacw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–17245 Filed 7–25–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Science and Technology Directorate
Notice of Public Meeting of the Project
25 Compliance Assessment Program
Governing Board
Science and Technology
Directorate, DHS.
ACTION: Notice of Public Meeting.
AGENCY:
SUMMARY: The Department of Homeland
Security’s (DHS) Office for
Interoperability and Compatibility (OIC)
will hold a public meeting of its Project
25 (P25) Compliance Assessment
Program (CAP) Governing Board (GB).
The P25 CAP GB is composed of public
sector officials who represent the
collective interest of organizations that
procure P25 equipment. The purpose of
the meeting is to review and approve
the proposed Compliance Assessment
Bulletin(s).
If time permits, the P25 CAP GB will
take oral public comments during the
last ten minutes of the call. If you would
like to provide oral comments (two
minutes maximum), please indicate so
when registering for the conference call.
The P25 CAP GB also welcomes ongoing
written feedback on the program. To
provide your written comments
anytime, please visit https://
www.safecomprogram.gov/SAFECOM/
currentprojects/project25cap/.
DHS OIC will post details of the
meeting, including the agenda, ten
E:\FR\FM\28JYN1.SGM
28JYN1
]]>Agencies
[Federal Register Volume 73, Number 145 (Monday, July 28, 2008)]
[Notices]
[Page 43764]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-17245]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Synthesis of Stable Isotope-Labeled Steroids as Internal
Standards for the Measurement of Endogenous Steroid Hormones in
Biologic Samples by Liquid Chromatography.
Date: August 26, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6130 Executive Boulevard,
Conference Room 319, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Kenneth L. Bielat, PhD, Scientific Review
Officer, Special Review Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7147, Bethesda, MD 20892-8329, 301-496-7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Altered Isoflavone Soybeans for Hormone-Responsive Cancer.
Date: September 8, 2008.
Time: 12:30 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 607, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Marvin L. Salin, PhD, Scientific Review Officer,
Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7073, Bethesda, MD 20892-8329, 301-496-0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SPORE in Breast, Brain, GI, HN, Ovarian, and Pancreatic
Cancers.
Date: September 24-25, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Shamala K. Srinivas, PhD, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 8123, Bethesda, MD 20892, 301-594-1224, ss537t@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Discovery and Development.
Date: October 1-2, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, Double Tree Name Changed,
1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Caron Lyman, PhD, Scientific Review Officer,
Division of Extramural Activities, National Cancer Institute,
National Institutes of Health, 6116 Executive Blvd, Room 8119,
Bethesda, MD 20892-8328, 301-451-4761, lymanc@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Clinical Studies I P01.
Date: October 6-7, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville Executive Mtg Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Majed M. Hamawy, PhD, MBA, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 8135, Bethesda, MD 20892-8328, 301-594-5659, mh101v@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Clinical Studies II P01.
Date: October 7, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, Double Tree Name Changed,
1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Peter J. Wirth, PhD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, 6116 Executive Boulevard, Room 8131,
Bethesda, MD 20892-8328, 301-496-7565, pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Prevention, Control and Population Sciences.
Date: October 7-8, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, Double Tree Name Changed,
1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Blvd., Room
8131, Bethesda, MD 20892, 301-594-1402, lopacw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-17245 Filed 7-25-08; 8:45 am]
BILLING CODE 4140-01-P
